Danieli
Based on the provided content, it is difficult to determine the firm's overall investment thesis and strategy as Maddyness appears to be primarily a news media outlet covering the French tech and startup ecosystem. The portfolio section of Maddyness highlights various startups and funds, but it doesn't explicitly outline Danieli's investment philosophy or approach. We can infer that their strategy likely involves early-stage investing given the focus on startups. However, without more information, it's impossible to provide a detailed summary. Maddyness is dedicated to helping entrepreneurs find the right investor by providing portraits of different funds. This suggests an informational role rather than a direct investment summary.
Danish BioInnovation Institute
Danish BioInnovation Institute (BII) is a venture capital firm focused on supporting early-stage start-ups and spin-out companies within human health, planetary health, and societal resilience. They aim to translate scientific breakthroughs into innovative products and solutions. BII provides funding, lab and office space, and comprehensive support to help entrepreneurs accelerate their journey towards validated ventures and company creation. Their programs include Venture Lab, Bio Studio, and Quantum Lab, each tailored to specific stages and areas of innovation. They actively foster a community where scientific discoveries can be transformed into viable businesses, contributing to a better world by addressing pressing global challenges in health and sustainability. They provide access to state-of-the-art laboratories, resources, and support systems to ensure their portfolio companies have the environment to thrive and develop cutting-edge technologies and solutions. BII operates through a series of focused programs designed to support start-ups at various stages. The Venture Lab program is for early-stage start-ups providing up to DKK 4M in funding to accelerate venture validation. The Bio Studio program supports entrepreneurial academic researchers in translating their science into innovative products and solutions, offering up to DKK 5.35M funding per year for three years. The Quantum Lab focuses on early-stage quantum technology startups in collaboration with NATO DIANA. In addition to funding, BII provides access to fully equipped laboratories, office spaces, and other essential infrastructure, allowing companies to focus on their research and development. BII's approach extends beyond mere financial investment. They provide extensive support services, including waste management, access to basic laboratory gases, consumables, and equipment, autoclaving and dishwashing services, and cryo/freezer storage space. They also assist with regulatory compliance, such as advising on work related to genetically modified organisms. This holistic support system is designed to minimize operational burdens and maximize the efficiency of their portfolio companies. By combining funding, facilities, and expertise, BII aims to create an ecosystem where innovation can flourish and impactful solutions can be developed and brought to market. BII demonstrates its commitment to creating societal impact through focusing its investments in areas critical to the future, such as human health, planetary health, and societal resilience. This is further supported by their collaborative environment in which portfolio companies can collaborate and leverage on shared knowledge and facilities. This is enhanced by the dedicated program support, specifically tailored to the needs of the different stages of growth and innovation. In addition, BII provides access to expert guidance, equipment, and facilities that enable the development and validation of novel technologies. By actively seeking and supporting changemakers, BII fosters an ecosystem conducive to the growth of innovative start-ups and spin-outs capable of addressing complex global challenges. They have achieved substantial traction, having supported 131 start-ups to date and contributing to the launch of 21 products on the market. With €139M in total funding and a portfolio that has collectively raised €1B in external funding, BII underscores its role as a significant catalyst for bioinnovation and a valuable partner for entrepreneurs seeking to translate scientific ideas into tangible solutions.
Danish Industry Foundation (Industriens Fond)
Industriens Fond (the Danish Industry Foundation) supports projects that benefit Danish companies. Their primary focus is on creating and applying new knowledge within the Danish business sector, viewing it as a fundamental driver for growth. They aim to ensure companies have access to employees with the necessary knowledge and skills to foster growth, emphasizing the importance of innovation to empower SMEs and entrepreneurs, granting them access to new markets and opportunities. The foundation achieves this through providing knowledge, developing competencies and fostering innovation in Danish businesses.
De Nora
Invests in early-stage technologies and startups in electrochemical, water treatment, and energy transition sectors to drive strategic innovation and sustainable growth.
DeBa Ventures
DeBa Ventures is a venture capital firm focused on discovering, supporting, and promoting founders crafting the future of fintech. They are more than just investors; they aim to be partners in shaping the future of the fintech industry by seeking out passionate entrepreneurs solving real-world problems through innovation. The firm emphasizes a founder-driven approach, leveraging the experience of their team, which includes successful exited entrepreneurs and seasoned fund managers. They provide tailored mentorship and strategic support, recognizing the unique challenges startups face. DeBa Ventures offers flexible investment models and fosters a collaborative partnership through their network of experts and advisors, combined with regular strategic sessions. Their investment strategy is global and prioritizes fintech companies, along with B2B, AI and SaaS, reflecting a commitment to fostering innovation in these dynamic sectors without geographical limitations. They believe in nurturing innovation and building a collaborative journey with visionary founders. The firm's mission is to uncover, nurture, and elevate the entrepreneurs shaping the future. DeBa Ventures distinguishes itself with a unique shared success model, allocating 10% of their profits back to the employees of their portfolio companies, acknowledging their contributions to collective achievements and growth. This policy reflects their belief in rewarding dedication and hard work, creating a mutually beneficial partnership. They measure their achievements by the great entrepreneurs they partner with, highlighting their portfolio's forward-looking companies.
Debiopharm Innovation Fund
Debiopharm Innovation Fund invests in digital health and smart data start-ups with the aim to improve patient outcomes and quality of life, particularly in oncology and infectious diseases. They seek to establish tomorrow's standard of care by enabling innovation in drug development, drug manufacturing, and digital health. The fund focuses on companies applying AI and data-driven insights to accelerate clinical trials, improve patient outcomes, and enhance drug discovery. They aim to leverage new imaging digital biomarkers from longitudinal images to help Debiopharm accelerate time to market and improve success rates of clinical trials, and are exploring digital twins for use in virtual control arms. The fund invests in areas that can significantly reduce the time and costs of clinical trials, more accurately predict patient outcomes, or enhance drug discovery using AI and data analytics. They are interested in platforms that can acquire imaging data from trial sites and generate clinically meaningful predictions from imaging data. Additionally, they seek opportunities in areas like collaborative software platforms for expanded access to medicines, cancer data aggregation and analytics platforms for precision oncology, and privacy-preserving data collaboration platforms. Debiopharm's investment strategy is driven by a desire to positively contribute to society and the environment through corporate responsibility. The fund supports projects and works that aim at improving the quality of life for patients. They actively seek out entrepreneurs with ambitions to take their professional endeavors to the next level and provide funding and support to help them achieve their goals. They appear to be interested in solutions related to in-vivo study design, AI-driven data cleaning, precision medicine in radiology, AI for clinical teams and multimodal AI models for histology images.
Decasonic
Decasonic is a venture and digital assets fund focused on building blockchain and AI innovation. They invest in early-stage companies in the Web3 and AI supercycle, emphasizing a product-first and thesis-driven approach. The firm aims to partner closely with founders building durable companies through periods of technological and market change. They draw on decades of experience as tech investors and operators to help founders in blockchain accelerate product-market fit and scale growth. The firm believes that blockchain and AI are at a similar stage as the internet in 2000 and that tomorrow's killer apps represent trillion-dollar opportunities. Decasonic seeks to partner with outlier founders who generate 100x+ outcomes. They operate like outlier founders, demonstrating dedication to building blockchain and AI innovation.
Decelera Ventures
Decelera Ventures is a founder-centric venture capital fund that invests in mission-driven founders with the potential to build transformative, sustainable companies. They operate a 'startup decelerator,' focusing on providing early-stage ventures with the tools and support to unlock their full potential. Their investment approach centers on the people behind the companies, emphasizing resilience, vision, and leadership. Decelera aims to create a profound and lasting impact on both companies and founders, empowering them to grow and thrive in a competitive market. Decelera's strategy involves a unique program located in Menorca, Spain, designed to foster purposeful growth. The program helps founders validate their business models while providing deep insights into their team’s potential and readiness to scale. The firm believes that growth requires more than just capital, and their program acts as a personal and professional oasis for founders, focusing on community support and local ecosystem development. The firm is committed to supporting local and emerging ecosystems, contributing to tier two and three economies. They actively engage with the local community by partnering with public schools to offer entrepreneurship training to children and teenagers. The fund aims to build a global ecosystem of mission-driven entrepreneurs who address critical environmental and social challenges, fostering innovations that create a more sustainable world. Decelera combines visionary thinking with measurable results to ensure lasting impact. They are proactive and solution-oriented, tackling challenges with teamwork and encouraging collaboration. Their values include open communication, honesty, mutual respect, integrity, and transparency. They also aim for excellence and embrace constant improvement, fostering a professional yet enjoyable environment.
Declaration Partners
Declaration Partners aims to create value in private investments through deep sector expertise, differentiated access, and authentic partnerships, rooted in a family office heritage. They emphasize long-term partnership alignment to optimize shared outcomes, focusing on flexible capital deployment to achieve superior returns over the long term. Their strategies span Private Investments, Real Estate, and GP Solutions, reflecting a diversified approach to value creation. The firm is anchored by David M. Rubenstein and partners with like-minded entrepreneurs, operators, and investors to create the "next generation" of value. In Private Investments, the objective is to capture asymmetric upside from attractive growth companies across various economic cycles. The Real Estate strategy seeks to combine family office flexibility with institutional real estate experience to generate attractive risk-adjusted returns. The GP Solutions strategy appears to focus on assisting talented investors and entrepreneurs in building their firms. Declaration Partners highlights its family heritage, entrepreneurial mindset, investment flexibility, and long-term alignment as key advantages. They also emphasize their experienced investment team with sub-sector expertise, supported by an institutional investment management infrastructure, as well as their global network of entrepreneurs, executive relationships, and senior capital markets participants. Partnership, reputation, and integrity are also listed as core values. Overall, the firm's investment thesis appears to be centered on leveraging its family office roots, sector expertise, and extensive network to identify and partner with high-potential companies and investment managers across various asset classes, while prioritizing long-term value creation and alignment of interests.
Deep Capital
Deep Capital invests in businesses that drive systemic transformation through relentless innovation, disruptive technology, and strategic foresight. The firm prioritizes ventures that improve health, quality of life, promote equality, and safeguard the environment, avoiding short-term gains in favor of long-term, impactful growth. It targets underserved sectors and ecosystems that redefine progress and purpose.
Deep Science Ventures
Deep Science Ventures (DSV) is a venture creator focused on building companies that address significant global challenges in sectors like agriculture, computation, climate, pharma, and education. Their approach involves combining available scientific knowledge with 'founder-type scientists' to create high-impact ventures. Instead of traditional investing, they actively create companies from scratch, identifying opportunity areas within each sector and then assembling teams to build ventures targeting specific, impactful outcomes. This involves deep expertise and partnerships with industry leaders, a proven methodology, and de-risked ventures with world-class investor potential. DSV aims to develop ventures that are not only scientifically sound but also commercially viable and capable of attracting significant funding and achieving substantial portfolio valuation.
DeepTech & Climate Fund (DTCF)
DeepTech & Climate Fund (DTCF) invests in visionary companies driving breakthrough innovation and the transformation of the economy. As a long-term investor, they partner with entrepreneurs and other investors to back the technology champions of tomorrow. They focus on companies with long development cycles, deep technology roots, and bold visions, aiming to strengthen Europe's global competitiveness. DTCF provides capital, expertise, and strategic support to navigate complex growth journeys and reach international markets. They build bridges between high-tech startups, SMEs, and long-term-oriented investors to drive sustainable success. The fund's goal is to be a long-term partner for transformative innovation throughout every growth stage, supporting companies to scale through buy-and-build strategies, enter new markets, and design future-ready exit paths.
DeepTechXL
DeepTechXL specializes in deep-tech investments, leveraging expertise and networks from leading tech corporates, knowledge institutes, and impact investors to accelerate time-to-market for deep-tech ventures through access to resources, technologies, licenses, supply chain partners, and co-investors.
DeepWater
Information not available.
Deepbridge Capital
Deepbridge Capital aims to redefine the growth capital market by providing investors with access to opportunities in technology, life sciences, and renewable energy sectors, sourced, reviewed, and managed by their team of sector specialists. They focus on supporting energetic, passionate, and knowledgeable management teams to help their businesses achieve their full potential and provide optimum returns for investors. Deepbridge offers various investment products, including EIS and SEIS funds, catering to different risk profiles and investment goals. The firm places emphasis on understanding the operational aspects of investee companies to effectively support, mentor, and manage those businesses through their funding journey, from seed stage through commercialization and growth funding. Deepbridge uses a rigorous investment process, including a Supervisory Investment Committee which provides oversight on the technical and commercial elements of proposed and executed investments. This committee, comprised of Deepbridge executives and independent experts, ensures investments align with the mandate of their products and services. They emphasize a culture of professional excellence and integrity, encouraging investee companies to achieve the highest standards of corporate governance. They aim to mitigate risk through deep due diligence, sectoral expertise, and active management. They offer the FlexEIS, a revolutionary approach enabling financial advisers to recommend investments in the Deepbridge Life Sciences EIS and Deepbridge Technology Growth EIS funds, aligning growth-focused venture capital with regular financial planning. This method allows investors to benefit from the tax reliefs of the Enterprise Investment Scheme (EIS) on an ongoing basis, rather than through traditional annual lump sum commitments, starting from £1,000 per month per fund. The firm also offers the Private Investor Network enabling experienced investors to define their own portfolio of innovative Life Sciences and Technology companies. Tax benefits are a key component of Deepbridge's investment offerings. They highlight the potential for 30% income tax relief, capital gains tax deferral, no capital gains tax on disposal of shares held for at least three years, inheritance tax exemption, and loss relief. They actively use the Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS) to provide tax advantages to investors. Deepbridge manages various products based on SEIS and EIS criteria, providing opportunities to participate in portfolios of seed-stage technology innovation companies, growth-focused technology companies, and healthcare innovation companies, while taking advantage of potential tax benefits.
Deepbridge Capital LLP
Deepbridge Capital is a growth capital specialist focusing on the technology, life sciences, and renewable energy sectors. They aim to provide investors with tax-efficient investment opportunities by leveraging the Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS). Their investment strategy involves supporting energetic, high-performance management teams and working with investee companies throughout their funding journey, from seed stage through commercialization and growth funding. This hands-on approach ensures investee companies have the best opportunity to succeed and provides investors with an optimum return.
Defence and Security Accelerator (UK)
The Defence and Security Accelerator (DASA), now part of UK Defence Innovation (UKDI), operates within the UK government to find and fund innovative technologies and solutions that can enhance defense and security capabilities. Their investment thesis revolves around identifying promising innovations from a broad range of sources, including academia, startups, and established companies, and providing them with the funding and support needed to mature their technologies and demonstrate their potential impact. UKDI/DASA aims to accelerate the development and deployment of solutions that address specific challenges and capability gaps identified by the Ministry of Defence (MOD) and other government agencies.
Defta Partners
DEFTA Partners has been investing in innovative technologies since the 1980s. They focus on identifying, nurturing, and funding companies with the potential for global success, leveraging their offices in San Francisco, Tokyo, and Hong Kong to support international expansion. Their initial vision centered around the shift to a pervasive ubiquitous communications (PUC) model, guiding investments in embedded devices, digital TV, and online security. This foresight allowed them to capitalize on early trends in information technology. Expanding on their early success, DEFTA Partners focuses on companies that can scale up internationally, particularly in the developing world. This is demonstrated by their work with BRAC in Bangladesh, establishing an internet service provider. Their long-standing experience in the ICT sector and commitment to hands-on global expertise highlight their strategy of actively supporting portfolio companies. Currently, DEFTA Partners sees new opportunities in the convergence of information and communication technology, biotechnology, pharmaceuticals, and other healthcare fields. They aim to enable individuals to live healthier lives through investments in advanced therapeutics, health ICT, and enabling technologies. This reflects their evolving investment strategy, aligning with emerging trends and societal needs.
Delft Enterprises
Delft Enterprises is the investment arm of Delft University of Technology (TU Delft). Their investment thesis centers around translating cutting-edge, science-based innovations from TU Delft into successful, impactful companies. They aim to empower and accelerate the development of early-stage, technology-driven spin-offs, contributing to TU Delft's mission of generating economic and social value from its research. They achieve this through a combination of direct investment, strategic advice, and leveraging a broad network of investors and experts. The firm focuses on deep tech ventures addressing significant societal challenges. They support entrepreneurial employees of TU Delft from the initial invention and patent stages through strategy development and startup formation. Delft Enterprises provides not only financial backing but also helps build networks with other investors and relevant partners. They emphasize transparency in intellectual property transfer through transparent deal term principles designed to expedite negotiations between the university and its spin-offs, fostering growth and success. Delft Enterprises is deeply integrated within the TU Delft ecosystem, actively involved in innovation hubs like The Green Village, YES!Delft, and RoboHouse. This close relationship provides them with a unique vantage point to identify and support promising technologies and teams emerging from the university. They aim to create an impact and creativity hotspot on the TU Delft campus, driving the commercialization of science for a better society. Furthermore, they actively participate in various venture capital funds, extending their reach and providing additional funding opportunities for promising technologies. They provide various funding instruments to support entrepreneurial employees and students in the early stages of product or process development.
Deloitte
Deloitte, as a global professional services firm, does not operate as a traditional venture capital firm. Instead, it provides consulting, advisory, audit, and tax services to various industries. The firm's strategy revolves around leveraging its global network, deep industry knowledge, and technological capabilities to help clients address complex business challenges, digitally optimize their operations, and thrive in a rapidly changing world. Deloitte focuses on delivering value by connecting proprietary insights, experience, and ecosystems to enable sustainable growth for its clients. This involves collaborating with companies to balance patient demands, market potential, and policy compliance, while continuing to help them innovate. Deloitte also provides strategic advice and insights on sustainability, digital transformation, and operational efficiency, aiming to help clients navigate evolving market needs and realize long-term value. Deloitte's approach is to offer integrated solutions that combine insight and innovation from multiple disciplines. They assist organizations in making strategic decisions related to technology adoption, supply chain optimization, and regulatory compliance. In the healthcare sector, for instance, they focus on transforming the journey of care by addressing the differentiated needs of healthcare stakeholders. In the consumer products industry, they help businesses shape strategies that address sustainability demands and digital imperatives. For investment management firms, Deloitte aims to drive a more sustainable, digital, and trustworthy financial network. Their overall strategy is to be a trusted advisor, helping clients capitalize on business opportunities and overcome challenges across various sectors. Deloitte's value proposition lies in its ability to provide data-driven insights and customized solutions that address specific industry challenges. They engage with clients to understand their unique needs and develop strategies that align with their goals, leveraging advanced technologies and digital engagement systems. They aim to help clients navigate complex issues such as climate change, digital transformation, and evolving consumer behaviors. Deloitte's work in the Health & Human Services sector involves connecting health services and social care organizations with actionable insights and solutions to support communities and improve public health outcomes. Their engagements are aimed at supporting clients in achieving strategic outcomes through integrated consulting and advisory services. Furthermore, Deloitte leverages its research and data analytics capabilities to provide insights into emerging trends and consumer behaviors. Through initiatives like ConsumerSignals, they offer data-driven insights to help businesses understand and navigate fast-changing times. In the automotive industry, they help companies formulate and implement business strategies around smart mobility and sustainability. In the energy sector, they work with innovative companies to address humanity’s pressing challenges related to energy security, affordability, and environmental sustainability. This integrated approach allows Deloitte to offer solutions that are both strategic and actionable, helping clients achieve their business goals and adapt to the future.
Delphi Digital
Delphi Digital provides crypto research for investors and builders. They aim to offer actionable research and an exclusive community to give members an edge in the crypto markets. The firm has been trusted by industry leaders since 2018. Their offering includes access to research reports, a community forum, and potential predictions or market outlooks. They appear to focus on providing in-depth analysis to help clients develop a comprehensive understanding of the crypto landscape. Their research is highlighted as being able to separate signal from noise in the crypto space, aiding investors and analysts. The testimonials suggest that Delphi's research and community are valuable resources for individuals and teams in the digital asset space.
Demea Sustainable Investment
Venture capital firm investing in high-growth technology companies.
Demeter
Demea Sustainable Investment focuses on supporting the energy and ecological transition by investing in companies and projects that contribute to a sustainable future.
Demeter Investment Managers
Demea Sustainable Investment is a major European player focusing on venture capital, private equity, and infrastructure investments within the energy and ecological transition sectors. Their investment strategy encompasses supporting companies at all stages of development, from innovative startups to small and mid-cap companies, and infrastructure projects. The firm aims to finance a sustainable future by allocating capital to businesses contributing to the energy and ecological transition. They actively participate in responsible and committed investing, demonstrated by their signatures on initiatives like PRI, CDP, iC20, The Shift Project, and gender diversity initiatives such as the France Invest gender equality charter, SISTA, and The Billion Dollar Fund for Women.